Results 101 to 110 of about 11,053 (191)

Varicella-Zoster Virus–Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults

open access: yes, 2017
The incidence and severity of herpes zoster (HZ) increases with age. The live attenuated zoster vaccine generates immune responses similar to HZ.
Jennifer Canniff   +6 more
core   +1 more source

A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates

open access: yesFrontiers in Immunology
Herpes zoster (HZ), also known as shingles, remains a significant global health issue and most commonly seen in elderly individuals with an early exposure history to varicella-zoster virus (VZV).
Yuanyuan Li   +11 more
doaj   +1 more source

Incidence of Herpes Zoster virus in the USA and the importance of the Zoster vaccine

open access: yes, 2022
Varicella zoster virus (VZV) is a herpes simplex virus that causes a primary infection that manifests as Varicella (chickenpox) and a reactivation of latent VZV as herpes zoster (shingles). In the United States the annual incidence of herpes zoster range
Shepherd-Hall, Janiline
core  

Prevention of Herpes Zoster : Recommendations of the Advisory Committee on Immunization Practices (ACIP) [PDF]

open access: yes
"These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licensed by ...

core  

Patient report of herpes zoster pain: Incremental benefits of zoster vaccine live. [PDF]

open access: yesVaccine, 2019
Bruxvoort KJ   +9 more
europepmc   +1 more source

Humoral and Cellular Immunogenicity of Zoster Vaccine within One Year after Herpes Zoster

open access: yes, 2017
Background Herpes zoster vaccination is recommended to patients with a prior history of herpes zoster to prevent reactivation. However, the appropriate timing of vaccination is controversial.
June Young Chun   +10 more
core   +1 more source

Varicella-zoster virus vaccine, successes and difficulties

open access: yes
Despite intensive efforts in recent decades to develop preventive or therapeutic vaccines against diseases caused by herpes simplex virus (HSV), or varicella-zoster virus (VZV), members of the Alpha herpes virinae subfamily of human herpes viruses,a safe
Sarkadi, Julia
core   +1 more source

Deep Sequencing of Distinct Preparations of the Live Attenuated Varicella-Zoster Virus Vaccine Reveals a Conserved Core of Attenuating Single-Nucleotide Polymorphisms [PDF]

open access: yes, 2016
The continued success of the live attenuated varicella-zoster virus vaccine in preventing varicella-zoster and herpes zoster is well documented, as are many of the mutations that contribute to the attenuation of the vOka virus for replication in skin. At
Gershon, AA   +4 more
core  

Effectiveness of the live zoster vaccine in patients with type 2 diabetes: a nationwide emulated target trial

open access: yes
Objectives: Real-world studies on its effectiveness in patients with type 2 diabetes mellitus (T2DM) remain limited. This study aimed to evaluate the effectiveness of the live zoster vaccine in patients with T2DM more than 10 years.Methods: In this ...
Dong Keon Yon (3843409)   +14 more
core  

Comparison of Vaccine Adverse Events Between Zoster Vaccine Live and Recombinant Zoster Vaccine: A Prospective Multicenter Survey. [PDF]

open access: yesJ Korean Med Sci
Yoon JG   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy